Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China
· Delayed Price · Currency is CNY 33.93
-0.26 (-0.76%)
Mar 9, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 13.55 billion as of March 9, 2026. Its market cap has increased by 105.28% in one year.
Market Cap
13.55B
Enterprise Value
14.80B
Revenue
662.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.93
Market Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 13.55B, an increase of 38.42%. That is a compound annual growth rate of 8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.66B | -11.13% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 13.33B |
| Vcanbio Cell & Gene Engineering Corp., | 14.09B |
| Tibet Cheezheng Tibetan Medicine | 14.22B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 13.01B |
| InventisBio | 12.37B |
| Staidson (Beijing) BioPharmaceuticals | 12.35B |
| Inner Mongolia Furui Medical Science | 15.10B |
| Beijing Hotgen Biotech | 11.90B |